Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ · Healthcare
Xeris Biopharma Holdings, Inc. Shareholder Equity 2020–2025
Xeris Biopharma Holdings, Inc. annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Xeris Biopharma Holdings, Inc. shareholder equity as of December 31, 2025: 13.7M, a 146.22% decrease year-over-year.
- Xeris Biopharma Holdings, Inc. shareholder equity for 2025 were 13.7M, a 146.22% decrease from 2024.
- Xeris Biopharma Holdings, Inc. shareholder equity for 2024 were -29.6M, a 336.67% increase from 2023.
- Xeris Biopharma Holdings, Inc. shareholder equity for 2023 were -6.8M, a 115.01% decrease from 2022.
- Xeris Biopharma Holdings, Inc. shareholder equity for 2022 were 45.2M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Xeris Biopharma Holdings, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $14 |
| 2024 | $-30 |
| 2023 | $-7 |
| 2022 | $45 |
| 2021 | $95 |
| 2020 | $34 |
Xeris Biopharma Holdings, Inc. Shareholder Equity — FAQ
Xeris Biopharma Holdings, Inc. (XERS) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XERS's shareholder equity history?
The chart and table above show Xeris Biopharma Holdings, Inc.'s shareholder equity by year and by quarter, including the growth rate.